Oncology & Cancer

Promising results for a new bowel cancer treatment

A new tablet treatment called divarasib has shown it is very effective in treating a challenging type of bowel (colorectal) cancer associated with the KRAS G12C mutation.

Immunology

Immune cells identified as 'metabolic factories' in the gut

A research team from MedUni Vienna has now demonstrated for the first time the central role of macrophages in the renewal of intestinal cells, which sheds light on the complex interplay between immune cells and tissue regeneration. ...

Oncology & Cancer

Research breakthrough sparks new hope for bowel cancer patients

Every year, over 15,500 Australians are diagnosed with bowel cancer, and it is the second leading cause of cancer deaths in the country. Over 1,700 (one in 10) of those diagnosed are young Australians aged under 50, and this ...

page 3 from 40